2 news items
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
HRTX
29 May 24
.
Important Safety Information for Patients
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
HRTX
12 Mar 24
including foot and ankle, and other procedures in which direct exposure to articular cartilage is avoided. Safety and efficacy have not been established
- Prev
- 1
- Next